These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
723 related items for PubMed ID: 33727797
1. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions. Li W, Wang Y, Pei Y, Xia Y. Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797 [Abstract] [Full Text] [Related]
2. Evaluation of Ornidazole Tablets Bioequivalence in Chinese Healthy Participants Under Fasted and Fed Conditions Using Pharmacokinetic Parameters. Wang Y, He Y, Li W, Li H, Tang L, Dai X, Pei Y, Gao L. Drugs R D; 2024 Jun; 24(2):145-154. PubMed ID: 38644462 [Abstract] [Full Text] [Related]
3. Relative bioavailability of two 5-mg montelukast sodium chewable tablets: a single dose, randomized, open-label, 2-period crossover comparison in healthy korean adult male volunteers. Kim HT, Song YK, Lee SD, Park Y, Kim CK. Arzneimittelforschung; 2012 Mar; 62(3):123-7. PubMed ID: 22407900 [Abstract] [Full Text] [Related]
4. Pharmacokinetics and Bioequivalence of Two Formulations of Azithromycin Tablets: A Randomized, Single-Dose, Three-Period, Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions. Chen Y, Ye L, Mei J, Tian M, Xu M, Jin Q, Yu X, Yang S, Wang J. Drugs R D; 2024 Jun; 24(2):201-209. PubMed ID: 38811485 [Abstract] [Full Text] [Related]
7. Investigation of the bioequivalence of montelukast chewable tablets after a single oral administration using a validated LC-MS/MS method. Zaid AN, Abualhasan MN, Watson DG, Mousa A, Ghazal N, Bustami R. Drug Des Devel Ther; 2015 Jun; 9():5315-21. PubMed ID: 26451086 [Abstract] [Full Text] [Related]
10. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects. Sun F, Liu Y, Li T, Lin P, Jiang X, Li X, Wang C, Gao X, Ma Y, Fu Y, Cao Y. BMC Pharmacol Toxicol; 2023 Feb 03; 24(1):7. PubMed ID: 36737825 [Abstract] [Full Text] [Related]
12. Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States. Bai W, Sun X, Qiu B, Guo C, Song H, Hu Y, Zhang X, Yin P, Wang X, Dong Z. Drug Des Devel Ther; 2024 Feb 03; 18():2273-2285. PubMed ID: 38895175 [Abstract] [Full Text] [Related]
14. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions. Chu NN, Zhang L, Wang J, Gu X, Ding Y, Huang K, Que LL, He Q. Clin Drug Investig; 2022 Jan 03; 42(1):53-63. PubMed ID: 34837169 [Abstract] [Full Text] [Related]
15. Bioequivalence studies of film-coated tablet and chewable tablet generic formulations of montelukast in healthy volunteers. Cánovas M, Arcabell M, Martínez G, Canals M, Cabré F. Arzneimittelforschung; 2011 Jan 03; 61(11):610-6. PubMed ID: 22232849 [Abstract] [Full Text] [Related]
16. Bioequivalence study of domperidone dry suspension in healthy Chinese subjects under fasted and fed conditions: An open-label, randomized, single-dose, crossover trial. Wu L, Huang Q, Lin M, Kai J, Huang Y, Zhai Y, Liu J, Shentu J. Int J Clin Pharmacol Ther; 2023 Jul 03; 61(7):320-328. PubMed ID: 36999513 [Abstract] [Full Text] [Related]
17. Bioequivalence study of two perindopril tert-butylamine tablet formulations in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial. Li Q, Hao Z, Yu Y, Tang Y. Biomed Pharmacother; 2021 Mar 03; 135():111221. PubMed ID: 33433351 [Abstract] [Full Text] [Related]
19. Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers. Liu MY, Wang S, Yao WF, Wu HZ, Meng SN, Wei MJ. Clin Ther; 2009 Apr 03; 31(4):784-92. PubMed ID: 19446151 [Abstract] [Full Text] [Related]
20. Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial. Yang L, Zhang L, Luo Z. Drug Des Devel Ther; 2023 Apr 03; 17():2369-2381. PubMed ID: 37600497 [Abstract] [Full Text] [Related] Page: [Next] [New Search]